MaureenMeganO'BrienMD(She/Her)
Pediatric Hematology & Oncology • Aurora, COPediatric Hematologic Oncology
Professor, University of Colorado School of Medicine, Children's Hospital Colorado
Dr. O'Brien is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
13123 East 16th Avenue
Box B115
Aurora, CO 80045Phone+1 720-777-6863Fax+1 720-777-7227- Is this information wrong?
Education & Training
Stanford University School of MedicineMS, Epidemiology, 2007 - 2008
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pediatric Hematology/Oncology, 2004 - 2007
Children's Hospital/Boston Medical CenterResidency, Pediatrics, 2000 - 2003
Harvard Medical SchoolClass of 2000- Harvard UniversityAB, Biochemical Sciences, Summa Cum Laude, 1992 - 1996
Certifications & Licensure
CA State Medical License 2004 - Present
CO State Medical License 2023 - 2025
KY State Medical License 2021 - 2024
OH State Medical License 2009 - 2024
IN State Medical License 2021 - 2023
MA State Medical License 2003 - 2005- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Apr 14
- Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma Start of enrollment: 2012 Aug 01
- A Safety Study of SGN-CD19A for Leukemia and Lymphoma Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 12 citationsHigh-dose AraC is Essential for the Treatment of ML-DS Independent of Post-Induction MRD: Results of COG AAML1531.Johann Hitzler, Todd A. Alonzo, Robert B. Gerbing, Amy Beckman, Betsy A. Hirsch, Susana C. Raimondi, Karen M. Chisholm, Shelton A Viola, Lisa Eidenschink Brodersen, Mi...> ;Blood. 2021 Jul 28
- 3 citationsTreatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effectiveJeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino, Robin E. Norris, Lynn Lee, Benjamin Mizukawa, Maureen M. O'Brien, Christine L Philli...> ;Pediatric Blood & Cancer. 2021 May 21
- 2 citationsResults of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemiaMaureen M. O'Brien, Todd A. Alonzo, Todd Cooper, John E. Levine, Patrick A. Brown, Tamra Slone, Keith J. August, Bouchra Benettaib, Noha Biserna, Jennifer Poon, Meera ...> ;Pediatric Blood & Cancer. 2021 Mar 10
- Join now to see all
Abstracts/Posters
- Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid...Maureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute LeukemiaMaureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Maureen M O'Brien, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
